• Research Professor, Global Health
  • Research Professor, Health Metrics Sciences
  • Adjunct Research Professor, Health Services
Marcia Weaver

2301 5th Ave,
Suite 600
Box 359932
Seattle, WA 98121
United States

Phone Number: 
Select from the following:

Marcia Weaver, PhD is an economist who leads the Cost-Effectiveness research team at UW’s Institute for Health Metrics and Evaluation. Previously, she was Principal Investigator for the Integrated Infectious Disease Capacity Building Evaluation (IDCAP), which was awarded to Accordia Global Health Foundation by the Bill and Melinda Gates Foundation. IDCAP was a cluster randomized trial implemented by the Infectious Diseases Institute in Uganda with the goal of evaluating the cost- effectiveness of two methods to build capacity among mid-level health practitioners for the treatment and prevention of HIV, malaria, pneumonia and tuberculosis. In the United States, Professor Weaver has published on cost-effectiveness of interventions for people with HIV and chronic mental illness and substance abuse as part of the ‘‘HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study,” and on a joint campaign to promote influenza and pneumococcal vaccines.

Professor Weaver has published 70 articles in peer-reviewed journals. A Full list of publications is available here

  • PhD (University of Chicago)
  • MA (University of Chicago)
  • BA (Hampshire College)
Country Affiliations 
  • French
  • Mandarin
  • Spanish
Health Topics 
  • Burden of Disease
  • Child and Adolescent Health (incl. Pediatrics)
  • Clinical Mentoring
  • Cost-Effectiveness
  • Diarrheal Diseases
  • Distance Learning
  • Economics
  • Education and Training
  • Emergency Medicine
  • Health Economics
  • Health Financing
  • Health Outcomes
  • Health Systems Strengthening and Human Resources Development
  • HPV
  • Immunizations
  • Influenza
  • Malaria
  • Maternal Child Health (incl. Reproductive Health)
  • Mental Health
  • Metrics and Evaluation
  • Pulmonary Diseases and Pneumonia
  • Quality Improvement
  • STDs (other than HIV)
  • TB
  • Tobacco, Alcohol, and Drug Use

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SE, et al. Cost-effectiveness analysis of integration of care for people with HIV, chronic mental illness and substance abuse disorders. Journal of Mental Health Economics and Policy, 2009; 12: 33-46.

Weaver MR, Crozier I, Eleku S, Makanga G, Sebuyira LM, Nyakake, Thompson ML, Willis K. Capacity-Building and Clinical Competence in Infectious Disease in Uganda: A Mixed-Design Study with Pre/Post and Cluster Randomized Trial Components. PLoS One 2012; 7(12):e51319. doi:10.1371/journal.pone.0051319

Weaver MR, Burnett SM, Crozier I, Kinoti SN, Kirunda I, Mbonye MK, Naikoba S, Ronald A, Rubashembusya T, Zawedde S, Willis KS. Improving facility performance in Infectious Disease Care in Uganda: a mixed design study with pre/post and cluster randomized trial components. PLoS One, 2014; 9(8): e103017. doi:10.1371/journal.pone.0103017

Galagan S, Jed SL, Sumitani J, Gilvydis J, Bakor A, Barnhart S, Cooke R, Naidoo E, Winters, D, Weaver MR. Improving TB and HIV care in South Africa: Evaluation of an advanced TB/HIV course for health care workers. Open Forum Infectious Disease. (2017) 4 (2): ofw248.

Moses MW, Pedroza P, Baral R, Bloom S, Brown J, Chapin A, Compton K, Eldrenkamp E, Fullman N, Mumford JE, Nandakumar V, Rosettie K, Sadat N, Shonka T, Flaxman A, Vos T, Murray CJL, Weaver MR. Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilisation of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016. The Lancet Public Health (2018); 4: e49-e73